Jay W. Belle Isle

Before becoming LegalReader's Editor-in-Chief, Jay W. Belle Isle worked as a freelance copywriter with clients on four continents. Jay has a degree in Business Administration from Cleary University and a Juris Doctor from Thomas M. Cooley Law School. Jay has also worked as a contracts administrator for a DOD contractor specializing in vehicle armor.

Vermont Law on GMO Labeling Stands

Image: SustainablePulse.com 5/1/2015 Vermont may well be drawing the line in U.S. soil regarding genetically modified food. U.S. District Court Judge Christina Reiss rule that the Vermont law on GMO labeling stands. The law, effective July 1, 2016, requires that all foods containing GMO ingredients be labeled as such. Needless to say, the Grocery Manufacturers

Medtronic Plc Agrees to Consent Decree with the FDA

5/1/2015 Pending approval from U.S. district court in Minnesota, Medtronic Plc agrees to consent decree with the FDA regarding its SynchroMed implantable drug pump. The company will correct problems that cause the pumps to deliver either too little or too much medication. The pumps are used for treating cancer and chronic pain patients and those

Michigan Insurance Companies Push Radical No-fault Auto Insurance Changes

Image: Shutterstock 4/30/2015 Under the stated reason of lowering the state’s highest-in-the-nation rates, Michigan insurance companies push radical no-fault auto insurance changes. To that end, the insurance industry is generously donating to state legislators and it seems to be working. The controversial bills seem to have been fast-tracked having only one Senate hearing and three

Takeda Settles Actos Cases for $2.3B

4/30/2015 In a great example of “CYA,” Takeda settles Actos cases for $2.3B. The agreement, yet to be approved by the plaintiffs, is a result of last year’s whopping smackdown in which a federal jury awarded a shopkeeper $9B, payable by Takeda and it’s former partner, Eli Lilly & Co. The court reduced that award

FDA Issued Stop Distribution Letters to Companies Producing BMPEA-containing Supplements

4/29/2015 Pressure from various officials finally got the FDA to step in regarding beta-methylphenethylamine (BMPEA), a substance used in weight loss, energy boosting and pre-workout supplements. The FDA issued stop distribution letters to companies producing BMPEA-containing supplements. This is a move I can support, unlike many other FDA positions on non-Big Pharma products. Image: Wikipedia,

Tort Reform: What a Waste of Time

4/29/2015 There aren’t too many dirtier words for lawyers than “tort reform.” Well actually, it’s properly referred to as tort “reform,” the placement of the quotation marks being all-important. Much like platform shoes, tort reform’s time is over. Frankly, it shouldn’t have even begun. Hence, the rallying cry of “Tort reform: what a waste of

States Asking Big Pharma About Astronomical Drug Prices

Colorful Pills by Vera Kratochvil Continual increases have states asking big pharma about astronomical drug prices. Many states are even proposing legislation that will force big pharma to share its development costs and profits as justification for ever-increasing prices. Tony DeLuca, a democratic representative in Pennsylvania, introduced legislation this week saying, “We need to have some

Supreme Court Heard Arguments On Same-Sex Marriage Today

The U.S. Supreme Court heard arguments on same sex marriage today. Arguably one of the nation’s hottest hot topics, SCOTUS is preparing to drop the hammer once and for all on whether I can marry Brad Pitt. The actual decision won’t surface until June, which is fine because… summer wedding! The justices heard two and

Lawsuit Claims Monsanto Lied About Roundup Safety

A recently filed class action lawsuit claims Monsanto lied about Roundup safety. The suit, filed in the Superior Court of California, Los Angeles County claims that the mega-corporation’s herbicide is not safe for humans as has been promised by Monsanto. Monsanto states that Roundup targets a specific enzyme (EPSP synthase) that is only found in